|
|
ISN GO CME Meeting: 2nd OSEA Meeting - Part 2 |
|
Date: 23 October 2010Contact Person: Dr Huo Thi Bich Tran (
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
) ... |
|
|
ISN GO CME Meeting: 2nd OSEA Course - Symposium on Tropical Medicine in Nephrology and Annual Meeting of the Indonesian Society of Nephrology (INASN) 2010 |
|
Dates: 19-22 October 2010Contact Person: Dr Suhardjono (
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
) ... |
|
Molecularly targeted agents for renal cell carcinoma: The next generation ... - UroToday |
|
UroTodayWith the approval of several molecularly targeted agents over the past few years, the landscape of renal cell carcinoma (RCC) management has drastically ... |
|
Sustained response following sorafenib therapy in an older adult patient with ... - UroToday |
|
UroTodayThe prognosis for patients with renal cell carcinoma is very poor, with a five-year survival rate of less than 10%. Sorafenib is an orally administered ... |
|
Metastatic renal carcinoma: Evaluation of antiangiogenic therapy with dynamic ... - UroToday |
|
UroTodayIn two phase-III trials involving 51 patients with metastatic renal cell carcinoma (38 men, 13 women; age range, 30-80 years) receiving antiangiogenic drugs ... |
|
|
|
|
<< Start < Prev 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 Next > End >>
|
|
Page 1463 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
